🚀 RECENT AI SUCCESS

Our AI successfully predicted the gap for $SFIX and executed a BUY strategy, securing a +31.52% net profit.

UPGRADE TO SEE LIVE SIGNALS

$IMUX

Immunic Inc

United StatesUNITED STATES
FREE PREVIEW
AVG HISTORICAL GAP-0.09%
MAX GAP RECORD-5.98%
PREMIUM
AI ACCURACY RATE
92.4%
Unlock AI Insights 🔓

LAST 10 EARNINGS GAPS (%)

VOLATILITY & BIAS PROFILE

AVG VOLATILITY1.8%
Bullish Gaps
Bearish Gaps
Neutral

Intelligence Brief

Immunic, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on ulcerative colitis, Crohn’s disease, relapsing-remitting multiple sclerosis, and psoriasis. The firm’s products include IMU-838, IMU-935, and IMU-856. The company was founded in May 2003 and is headquartered in New York, NY. Read full dossier

CURRENT AI SIGNAL
BULLISH STRONG
🔓 REVEAL SIGNAL